Patent · US Active

Compositions and methods for inhibiting ribosome inactivating proteins

US12427135B2 · kind B2 · utility

0Cited by
1References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 9, 2022
Grant dateSep 30, 2025
Priority date
Expiry dateMar 9, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F5/025
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure provides in one aspect a method of treating, ameliorating, and/or preventing toxicity caused by a ribosome inactivating protein (RIP) in a subject. In certain embodiments, the method comprises administering to the subject a therapeutically effective amount of at least one compound of the disclosure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.